Sodium from restaurant food causes water retention
However: Larger meta-analyses show no significant increase in risk after adjusting for confounders [25] Incidence appears similar to other diabetes therapies [25] Much of the observed signal likely reflects: Baseline risk (obesity, T2DM) Secondary gallstone disease In summary, pancreatitis in GLP-1 users is a rare and possible complication, but current evidence does not support a substantial increase in risk directly related to GLP-1 agents
What is even more profound with bupropion is its apparent ability to allow for weight loss sustained over time
Intravenous (IV) infusions are one method
Neither product is categorically "better." They address different research needs
While data collection for overall survival continues, the consistency of the benefit observed on other clinically meaningful efficacy endpoints, together with improved quality of life and favorable safety profile, show the potential of Pluvicto for taxane-nave patients with mCRPC. References 1